plan
stop
ongo
epidem
must
base
quantit
understand
proport
atrisk
popul
need
protect
effect
control
measur
order
transmiss
declin
suffici
quickli
enough
epidem
end
use
seirtyp
transmiss
model
contrast
two
altern
strategi
model
proport
popul
need
protect
infect
onetim
vaccin
assum
effect
test
isol
treatment
individu
within
six
hour
symptom
onset
r
current
vaccin
herd
immun
coverag
would
drive
r
transmiss
could
persist
year
coverag
requir
end
epidem
month
populationwid
vaccin
epidem
could
end
year
test
isol
treatment
reach
symptomat
infect
patient
within
hour
symptom
onset
assum
asymptomat
transmiss
epidem
could
end
six
month
test
isol
treatment
reach
symptomat
patient
symptomat
patient
could
test
within
six
hour
symptom
appear
epidem
could
end
four
month
plan
stop
ongo
epidem
must
base
quantit
understand
proport
atrisk
popul
need
protect
effect
control
measur
order
transmiss
declin
suffici
quickli
enough
epidem
end
end
epidem
requir
reduc
basic
reproduct
number
r
averag
number
peopl
infect
patient
point
transmiss
contract
eventu
burn
howev
r
brought
margin
transmiss
could
still
linger
year
enough
infect
could
occur
time
especi
given
high
mobil
peopl
densiti
urban
area
new
hotspot
could
get
seed
transmiss
could
resurg
end
epidem
therefor
may
requir
get
r
drive
aggress
order
reach
zero
case
quickli
januari
mean
r
estim
upper
bound
confid
interv
infect
averag
result
two
infect
although
case
asymptomat
transmiss
document
world
health
organ
advis
transmiss
still
primarili
driven
symptomat
patient
order
bring
r
contrast
two
altern
strategi
model
proport
popul
need
protect
infect
onetim
vaccin
assum
effect
test
isol
treatment
individu
within
six
hour
symptom
onset
employ
seirtyp
transmiss
model
mean
incub
period
day
mean
infecti
period
day
initi
preval
novel
coronaviru
infect
popul
million
roughli
popul
wuhan
light
unknown
asymptomat
transmiss
fix
percentag
transmiss
model
prior
symptom
onset
current
r
atrisk
popul
respect
would
need
vaccin
order
bring
r
r
transmiss
occur
asymptomat
approxim
symptomat
individu
would
need
test
isol
treatment
within
six
hour
respect
symptom
onset
order
bring
r
asymptomat
transmiss
account
overal
transmiss
coverag
would
need
reach
symptomat
individu
respect
r
transmiss
occur
asymptomat
test
isol
treatment
would
need
reach
symptomat
individu
done
within
six
hour
symptom
onset
respect
given
denomin
populationwid
vaccin
million
much
greater
proport
popul
concern
symptom
far
fewer
peopl
would
need
reach
test
isol
treatment
vaccin
achiev
herd
immun
model
number
day
would
take
get
zero
differ
rate
coverag
vaccin
test
isol
treatment
symptomat
infect
patient
figur
r
current
exampl
vaccin
herd
immun
coverag
would
drive
r
transmiss
could
persist
year
coverag
requir
end
epidem
month
populationwid
vaccin
epidem
could
end
year
test
isol
treatment
reach
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
symptomat
infect
patient
within
hour
symptom
onset
assum
asymptomat
transmiss
epidem
could
end
six
month
test
isol
treatment
reach
symptomat
patient
symptomat
patient
could
test
within
six
hour
symptom
appear
epidem
could
end
four
month
epidem
could
end
within
month
wide
usabl
diagnost
vaccin
could
develop
use
cover
suffici
proport
atrisk
popul
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
basic
reproduct
number
defin
averag
number
secondari
case
gener
primari
infecti
individu
earli
transmiss
phase
complet
suscept
popul
key
metric
gaug
intens
type
intervent
need
implement
order
bring
epidem
control
ongo
epidem
estim
upper
bound
confid
interv
employ
seirtyp
transmiss
model
evalu
effect
percentag
symptomat
individu
testedscreen
well
averag
time
take
bring
isol
treatment
popul
classifi
epidemiolog
state
suscept
expos
e
symptomat
infecti
individu
test
symptomat
infecti
individu
test
remain
commun
symptomat
individu
effect
isol
treat
j
recov
individu
r
schemat
diagram
model
given
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
b
transmiss
rate
q
paramet
rang
model
rel
infecti
individu
incub
period
diseas
expos
individu
progress
symptomat
phase
averag
day
wherea
averag
infecti
period
symptomat
individu
day
percentag
symptomat
individu
undergo
test
rang
averag
time
onset
symptom
isol
treatment
individu
undergo
test
rang
hour
reproduct
number
includ
effect
test
isol
treatment
symptomat
individu
given
absenc
test
basic
reproduct
number
simpli
given
b
qk
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
defin
vaccin
reproduct
number
rv
given
effect
vaccin
coverag
level
v
follow
v
proport
popul
effect
vaccin
model
averag
number
day
would
take
get
zero
case
reproduct
number
declin
epidem
threshold
variou
control
intervent
purpos
gener
stochast
simul
use
compartment
model
describ
previou
section
assum
initi
preval
novel
coronaviru
infect
popul
million
calcul
averag
number
day
get
zero
case
simul
total
stochast
epidem
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
figur
schemat
model
diagram
popul
classifi
epidemiolog
state
suscept
expos
e
symptomat
infecti
individu
test
symptomat
infecti
individu
test
remain
commun
symptomat
individu
effect
isol
treat
j
recov
individu
r
model
paramet
describ
tabl
